Company intelligence / Profile preview

Infinovo Medical

Nantong, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Infinovo Medical develops and manufactures continuous glucose monitoring (CGM) devices aimed at providing accurate and affordable real‑time glucose monitoring for people with type 1 and type 2 diabetes; its CGM hardware is also being commercialized in the veterinary market via partners.[1][2][4]

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

ALR Technologies SG Pte. Ltd. (manufacturing and supply agreement for CGM hardware used in GluCurve Pet CGM)[1][2][4]

Beyond the preview

Go deeper on Infinovo Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infinovo Medical.

Explore the full profile